Register Now - Every Drop Matters: Reducing Product Loss in Sterile Filtration
|Articles|July 1, 2002

NDA Approvals for Calendar Year 2001

1 JULY - NDA Approvals for Calendar Year 2001 http://www.fda.gov/cder/rdmt/ndaaps01cy.htm

NDA Approvals for Calendar Year 2001http://www.fda.gov/cder/rdmt/ndaaps01cy.htm


Related to this article

The BioPharm Brief: Long-Term Survival Data for a PD-L1/4-1BB Bispecific, Celldex Exits Atopic Dermatitis, and a Fc-Fusion GLP-1 Goes Global
Leads Biolabs details survival data and 2027 ADC combination plans for its PD-L1/4-1BB bispecific opamtistomig, Celldex Therapeutics ends its atopic dermatitis program for anti-KIT antibody barzolvolimab after a phase 2 miss, and Innogen licenses its Fc-fusion GLP-1 receptor agonist efsubaglutide alfa to Arcera Life Sciences for international markets.